Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsProcessa Pharmaceuticals, Inc. announced the successful completion of the safety tolerability evaluation in its Phase Ib trial of Next Generation Capecitabine.
[Processa Pharmaceuticals, Inc.]
Home Newsletters Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap...
